Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell Types

News   Nov 21, 2017

 
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell Types

Human neurons stained for MAP2 and synaptophysin

 
 
 

RELATED ARTICLES

Neurophysiological Measurements of Inner Speech Reveal an Efferent Copy

News

New research showing that talking to ourselves in our heads may be the same as speaking our thoughts out loud could help explain why people with mental illnesses such as schizophrenia hear voices.

READ MORE

Novel Isotope Tracking Method Offers Hope for Threatened Species

News

Locating even a single nest of the secretive goshawk required weeks of exploration. So scientists decided to conduct elemental analysis using strontium, which has naturally occurring isotopes found everywhere on Earth that travel the food chain from the soil to plants to herbivores and predators. Analysing prey remains enabled the researchers to determine where the birds of prey were hunting, findings that could help steer conservation efforts for goshawks and other vulnerable species.

READ MORE

New Drug Successfully Treats Huntington Patients

News

The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial, and successfully lowered the level of the harmful huntingtin protein in the nervous system.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE